[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Market Rebellion [@MarketRebels](/creator/twitter/MarketRebels) on x 347.2K followers Created: 2025-07-17 18:24:00 UTC Sarepta surges after strategic overhaul, cutting XX% of workforce & prioritizing siRNA assets. Aims for $400M annual savings, reaches FDA deal on ELEVIDYS labeling. $SRPT @jonnajarian @petenajarian #ITSNOTANOPTION  XXXXX engagements  **Related Topics** [$srpt](/topic/$srpt) [$400m](/topic/$400m) [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/MarketRebels/status/1945912384205513145)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Market Rebellion @MarketRebels on x 347.2K followers
Created: 2025-07-17 18:24:00 UTC
Sarepta surges after strategic overhaul, cutting XX% of workforce & prioritizing siRNA assets. Aims for $400M annual savings, reaches FDA deal on ELEVIDYS labeling. $SRPT @jonnajarian @petenajarian #ITSNOTANOPTION
XXXXX engagements
Related Topics $srpt $400m sarepta therapeutics inc stocks healthcare
/post/tweet::1945912384205513145